Tudor Investment Corp’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
+35,393
New +$965K 0.01% 2282
2025
Q4
Sell
-31,618
Closed -$818K 3617
2025
Q3
$818K Buy
+31,618
New +$733K 0.01% 2400
2025
Q2
Sell
-35,141
Closed -$638K 3385
2025
Q1
$638K Buy
35,141
+2,596
+8% +$58K 0.01% 2125
2024
Q4
$822K Buy
+32,545
New +$884K 0.01% 1869
2024
Q2
Sell
-67,384
Closed -$2.83M 2399
2024
Q1
$2.83M Buy
67,384
+52,842
+363% +$2.17M 0.03% 857
2023
Q4
$577K Sell
14,542
-7,496
-34% -$220K 0.01% 1723
2023
Q3
$606K Sell
22,038
-1,637
-7% -$51.3K 0.01% 1579
2023
Q2
$803K Sell
23,675
-3,600
-13% -$121K 0.01% 1431
2023
Q1
$981K Buy
+27,275
New +$1.18M 0.02% 1216
2019
Q1
Sell
-4,363
Closed -$13K 1114
2018
Q4
$13K Hold
4,363
﹤0.01% 977
2018
Q3
$30K Hold
4,363
﹤0.01% 1055
2018
Q2
$33K Sell
4,363
-1,404
-24% -$18.8K ﹤0.01% 1010
2018
Q1
$202K Sell
5,767
-1,088
-16% -$42.2K 0.01% 869
2017
Q4
$292K Buy
6,855
+2,878
+72% +$123K 0.02% 811
2017
Q3
$171K Buy
3,977
+3,010
+311% +$113K 0.01% 981
2017
Q2
$36K Buy
+967
New +$42.8K ﹤0.01% 987
2017
Q1
Sell
-3,187
Closed -$169K 1389
2016
Q4
$169K Buy
3,187
+2,293
+256% +$130K 0.01% 1251
2016
Q3
$54K Sell
894
-115
-11% -$7.16K ﹤0.01% 1369
2016
Q2
$66K Sell
1,009
-8,287
-89% -$526K ﹤0.01% 1541
2016
Q1
$527K Buy
9,296
+8,239
+779% +$927K 0.02% 909
2015
Q4
$249K Buy
+1,057
New +$230K 0.01% 1323
2015
Q2
Sell
-1,887
Closed -$789K 1513
2015
Q1
$789K Buy
+1,887
New +$675K 0.04% 482

Other funds holding CLDX